SPRY position history
The shares of Ars Pharmaceuticals (SPRY) that Third Point LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 556,237 shares, $6.5M, 0.09% of portfolio, New
- 2026 Q1: 1,000,000 shares, $8M, 0.39% of portfolio, Add +79.8%
- 2026 Q2: 1,000,000 shares, $8M, 0.17% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|